Announcements

Director Anne Arvia of GATX Corp filed a Form 144 notice on November 6, 2026, disclosing a proposed sale of 943 shares of GATX common stock under Rule 144 of the Securities Act of 1933.

CTT Pharmaceutical Holdings, Inc. filed a Statement of Changes in Beneficial Ownership on November 6, 2026, disclosing a purchase of 9,000 shares of CTTH common stock by the company's CEO and Director, Ryan Khouri, on November 4, 2026.

Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 6, 2026, disclosing preliminary terms for Autocallable Contingent Coupon Equity Linked Securities linked to Boston Scientific Corporation (BSX) with a stated principal amount of $1,000 per security and a maturity date of …

Director David Preston Hood filed a Form 4 with the SEC on November 6, 2026, disclosing the acquisition of restricted stock and stock options in Winchester Bancorp, Inc./MD/ (NASDAQ:WSBK) on November 4, 2026.

T. Rowe Price Investment Management, Inc. filed Amendment No. 6 to its Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 28,138,417 shares of Cabaletta Bio Inc. common stock as of October 31, 2026.

T. Rowe Price Associates, Inc. filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 33,445,993 shares of Pacific Biosciences of California common stock as of October 31, 2026.

April Pinkley, Chief Accounting Officer of Southside Bancshares Inc, filed a Form 4 on November 6, 2026, disclosing option exercises and open-market sales of common stock transacted on November 5, 2026.